"Illumina Reports 8% Sequential Revenue Growth in Q2, NovaSeq X Shipments Exceed Expectations," says Interim CEO Charles Dadswell

Revenue of $1.18 billion for Q2 2023, up 1% from Q2 2022 (up 3% on a constant currency basis) and up 8% from Q1 2023 Shipped 109 NovaSeq X instruments i...

August 10, 2023 | Thursday | Company results
Emergent's 2023 Milestones Bolster America's Preparedness for Public Health Challenges, Securing Financial Resilience, Declares CEO Haywood Miller

Reports Q2 2023 total revenues of $338M, above the prior guidance range, net loss of $261M and adjusted EBITDA of $56M Updates FY 2023 guidance and prov...

August 09, 2023 | Wednesday | Company results
Merck's CEO Belén Garijo Optimistic About 2023 as Healthcare Business Drives Growth

Financial results of Q2 2023 Net sales decrease organically by −1.1% to € 5.3 billion EBITDA pre down organically by −7.0% t...

August 08, 2023 | Tuesday | Company results
Agilent Announces Thought Leader Award to Peter Neubauer

-Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award. As Chair of...

August 07, 2023 | Monday | News
Gilead's Remarkable Q2 Performance: 11% Year-Over-Year Growth Fueled by Diverse Therapeutic Portfolio, Positive Regulatory Advances, and Promising Pipeline, Declares CEO Daniel O’Day

Product Sales Excluding Veklury Increased 11% Year-Over-Year to $6.3 billion Biktarvy Sales Increased 17% Year-Over-Year to $3.0 billion Oncology Sales...

August 07, 2023 | Monday | Company results
Piramal Pharma Reports Strong Start to Financial Year with Revenue Surge and Promising Growth Prospects Across Business Segments, Says Chairperson Nandini Piramal

Nandini Piramal, Chairperson, Piramal Pharma Limited said, "We had a positive start to the new financial year with healthy revenue growth and improvem...

August 04, 2023 | Friday | News
Clarify Health Appoints Terry Boch to Chief Commercial Officer

“We are thrilled to welcome Terry on board,” said Jean Drouin, MD, founder and CEO of Clarify Health. “Terry’s passion for our miss...

July 26, 2023 | Wednesday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
Thermo Fisher Scientific Elects New Director to Board

In a career at Franklin Templeton spanning 35 years, Johnson has been a key driver in the company's transformation to what is now one of the largest global...

July 14, 2023 | Friday | News
Biotech Executive Beth Thompson-Webb Joins Culture Biosciences’ Board of Directors

Culture Biosciences has appointed Beth Thompson-Webb, Chief Commercial Officer at Virica Biotech, as Independent Director to the company’s Board of D...

July 14, 2023 | Friday | News
SK Bioscience-Sanofi Announce Positive Phase II Results for Pneumococcal Vaccine

The 21-valent pneumococcal conjugate vaccine candidate, GBP410 (also known as SP0202), demonstrates positive safety and immunogenicit...

July 04, 2023 | Tuesday | News
Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer

Prior to joining Catalent, Mr. Masanovich served as Executive Vice President & Chief Financial Officer of Tenneco Automotive until it was acquired by A...

June 21, 2023 | Wednesday | News
Biotech Executive Michael Smith Discusses the FDA Drug Development Process with CancerVAX CEO Ryan Davies

CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body’s immune system to fight cancer,  announced that its CE...

June 19, 2023 | Monday | News
Samsung Biologics' Plant 5 and Bio Campus II Set to Redefine Biopharmaceutical Manufacturing

In a highly anticipated conversation with BioPharma BoardRoom, Eric Hsu, Director of Key Account Management at Samsung Biologics, shares groundbreaking ins...

June 14, 2023 | Wednesday | Opinion

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close